GMED Earnings Date: Nov 5, 2026 (Estimated) — Globus Medical, Inc.
NYSE · Healthcare · Medical Devices
Updated
When is GMED's next earnings date?
Globus Medical, Inc. (GMED) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $1.20 on revenue of $792.4M.
How did GMED do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Globus Medical, Inc. posted EPS of $1.34 versus the $1.10 estimate, a beat of 21.8%. Revenue was $789.6M against a $782.9M estimate. The stock's 1-day post-earnings move was +1.6%.
How much does GMED stock move after earnings?
GMED beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 9.4% (up or down) in the day after earnings.
About Globus Medical, Inc.
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | 1.10 | 1.34 | +21.82% | $789.6M | ✅ Beat | +1.57% | +5.99% | -3.44% |
| 2026-05-07 | Q1 2026 | 0.92 | 1.12 | +21.74% | $759.9M | ✅ Beat | -8.37% | -9.24% | -7.96% |
| 2026-02-24 | Q4 2025 | 1.12 | 1.28 | +14.29% | $826.4M | ✅ Beat | +4.72% | -0.20% | -4.93% |
| 2025-11-06 | Q3 2025 | 0.78 | 1.18 | +51.28% | $769.0M | ✅ Beat | +35.94% | +36.10% | +44.22% |
| 2025-08-07 | Q2 2025 | 0.76 | 0.86 | +13.16% | $745.3M | ✅ Beat | +8.47% | +11.00% | +10.13% |
| 2025-02-20 | Q4 2024 | 0.75 | 0.84 | +12.00% | $657.3M | ✅ Beat | -4.56% | -6.48% | -12.52% |
| 2024-11-05 | Q3 2024 | 0.65 | 0.83 | +27.69% | $625.7M | ✅ Beat | +9.43% | +10.37% | +9.94% |
| 2024-08-06 | Q2 2024 | 0.68 | 0.75 | +10.29% | $629.7M | ✅ Beat | +2.14% | -2.51% | +2.53% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q3 FY25 · $769.0M total
| Segment | Share | Revenue | YoY | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 |
|---|---|---|---|---|---|---|---|
| Spine | 96.4% | $741.0M | +26.2% | $574.7M | $592.9M | $587.4M | $610.3M |
| Emerging Technology | 3.6% | $28.0M | -26.8% | $32.0M | $36.8M | $38.3M | $47.0M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.